Propulsid and Macrodantin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Propulsid (cisapride monohydrate) and Macrodantin (nitrofurantoin, macrocrystalline). Common drug interactions include renal failure acute among females.

The phase IV clinical study analyzes what interactions people have when they take Propulsid and Macrodantin. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Propulsid?

Propulsid has active ingredients of cisapride monohydrate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 8,130 Propulsid users. Check the latest studies of Propulsid.

What is Macrodantin?

Macrodantin has active ingredients of nitrofurantoin, macrocrystalline. It is often used in urinary tract infection. eHealthMe is studying from 3,755 Macrodantin users. Check the latest studies of Macrodantin.



On Jul, 08, 2026

15 people who take Propulsid and Macrodantin together, and have interactions are studied.

Propulsid and Macrodantin drug interactions.

What are the common drug interactions of Propulsid and Macrodantin, by gender? *:

female:

  1. Renal failure acute (rapid kidney dysfunction)
  2. Abscess (pus)
  3. Back pain
  4. Cardiac failure congestive
  5. Cataract (clouding of the lens inside the eye)
  6. Constipation
  7. Dehydration (dryness resulting from the removal of water)
  8. Depression
  9. Diabetes mellitus inadequate control
  10. Drug hypersensitivity

male:

n/a

What are the common drug interactions of Propulsid and Macrodantin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Asthenia (weakness)
  2. Headache (pain in head)
  3. Influenza like illness
  4. Thinking abnormal

40-49:

  1. Contrast media reaction (reaction associated with the use of intravenous contrast material during radiology)
  2. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  3. Coronary artery thrombosis (clot formation in coronary artery)
  4. Cough
  5. Cystitis glandularis (forming a timorous lesion with blueberry spots in the urinary bladder)
  6. Deafness
  7. Decreased appetite
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Dehydration (dryness resulting from the removal of water)
  10. Depression

50-59:

  1. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
  2. Back pain
  3. Blindness unilateral
  4. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  5. Blood potassium decreased
  6. Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
  7. Cardiac failure congestive
  8. Cataract (clouding of the lens inside the eye)
  9. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  10. Congestive cardiomyopathy (weakening of heart muscle)

60+:

  1. Abdominal pain
  2. Constipation
  3. Death
  4. Drug hypersensitivity
  5. Electrocardiogram qt corrected interval prolonged
  6. Lethargy (tiredness)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 20.00%
  2. Stress And Anxiety: 1 person, 6.67%
  3. Sleep Disorder: 1 person, 6.67%
  4. Pulmonary Congestion (congestion in the lungs): 1 person, 6.67%
  5. Pain: 1 person, 6.67%
  6. Osteopenia (a condition where bone mineral density is lower than normal): 1 person, 6.67%
  7. Impaired Gastric Emptying: 1 person, 6.67%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 6.67%
  9. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 6.67%
  10. High Blood Pressure: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Propulsid and Macrodantin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Propulsid and Macrodantin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Propulsid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Macrodantin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Propulsid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Macrodantin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cisapride monohydrate and nitrofurantoin, macrocrystalline (the active ingredients of Propulsid and Macrodantin, respectively), and Propulsid and Macrodantin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: